Following the acquisition of Katalyst Surgical, Inc. in 2022, FCI is excited to announce the expansion of its vitreoretinal portfolio with advanced surgical retina products. Our newly expanded portfolio includes a wide range of vitreoretinal instrumentation, laser probes, illuminated laser probes, chandeliers, backflushes, and cannulas to provide added value to vitreoretinal surgeons.